Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Tuesday, May 5, 2026
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
SGS Acquires Keystone Bioanalytical to Expand North America Drug Testing Capabilities
Amazon Launches Amazon Supply Chain Services to Expand Logistics Capabilities for…
Latus Bio Secures $97 Million Series A to Advance Scalable Gene…
Lattice to Acquire AMI to Build Complete Secure Management Platform
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
Niko Gubernator
Niko Gubernator
Chemicals
eMolecules acquires Frontier Scientific Inc. and Frontier Agricultural Sciences Inc.
PR Newswire
-
September 8, 2022
eMolecules, Inc., provider of a leading chemistry search-and-fulfillment platform for early drug discovery research, announced the acquisitions of Frontier Scientific Inc. (FSI) and Frontier...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
SGS Acquires Keystone Bioanalytical to Expand North America Drug Testing Capabilities
Amazon Launches Amazon Supply Chain Services to Expand Logistics Capabilities for Global Businesses
Latus Bio Secures $97 Million Series A to Advance Scalable Gene Therapy for Broader Patient Populations
Load more
